lincomycin has been researched along with guaifenesin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Borishpolets, ZI; Chernysheva, TF; Kostiukova, NN; Mironova, TK; Sal'nikova, GP | 1 |
| Lee, SP | 1 |
1 review(s) available for lincomycin and guaifenesin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for lincomycin and guaifenesin
| Article | Year |
|---|---|
[Elective lincomycin medium for isolation of Meningococcus from the nasopharyngeal mucus].
Topics: Culture Media; Culture Techniques; Humans; Lincomycin; Mucus; Nasopharynx; Neisseria meningitidis | 1980 |
Hypersecretion of mucus glycoprotein by the gallbladder epithelium in experimental cholelithiasis.
Topics: Animals; Cholelithiasis; Cholestanol; Cholesterol; Cholic Acids; Disease Models, Animal; Epithelium; Female; Gallbladder; Glycoproteins; Guinea Pigs; Histocytochemistry; Lincomycin; Male; Mice; Mucus; Rabbits | 1981 |